Description: Evogene Ltd., a plant genomics company, engages in the development of enhanced plant traits through the use of plant genomics. It primarily focuses on the development of food crops, including corn, soybean, cotton, canola, rice, and wheat, as well as castor for the production of biofuel. The company's technologies include ATHLETE for gene discovery; Gene2Product for enhancing trait efficacy and probability of successful development of biotechnology seed products; and EvoBreed for breeding enhancement. It holds granted or pending patents to approximately 3,000 novel genes. The company has collaboration agreements with Bayer CropScience; Biogemma; Centre de Cooperation Internationale en Recherche Agronomique pour le Development; DuPont; Monsanto Company; Rahan Meristem (1998) LTD; Rasi Seeds (P) Ltd.; Syngenta; Vilmorin; Viterra; and Zeraim Gedera for the development of various products and provision of plant enhancement solutions. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
Home Page: www.evogene.com
EVGN Technical Analysis
13 Gad Feinstein Street
Rehovot,
7414002
Israel
Phone:
972 8 931 1900
Officers
| Name | Title |
|---|---|
| Mr. Ofer Haviv CPA | CEO & Pres |
| Mr. Mark Kapel | Chief Technology Officer |
| Dr. Elran Hillel Haber M.B.A., Ph.D. | Chief Exec. Officer of Biomica Ltd |
| Mr. Yaron Eldad | Chief Financial Officer |
| Dr. Eyal Emmanuel | Chief Scientific Officer |
| Mr. Sassi Masliah | Exec. VP of Corp. Devel. |
| Ms. Liat Foigel Wejgman | VP of HR |
| Dr. Nir Arbel | Chief Product Officer |
| Mr. Dotan Borenstein | Chief Bus. Officer of Lavie Bio Ltd. |
| Mr. Eyal Ronen | Exec. VP of Bus. Devel. |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9638 |
| Price-to-Sales TTM: | 21.988 |
| IPO Date: | 2008-03-05 |
| Fiscal Year End: | December |
| Full Time Employees: | 133 |